Richard L. Lindstrom M.D., Director at HARROW HEALTH, INC. (HROW), sold 80,000 shares at $12.62 ($1.0M) on 2022-09-30, disclosed to the SEC on 2022-10-03.
Open-market sale of $1.0M HROW by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.62 | 40,000 | $505K | 50.0% |
| 2 | $12.62 | 40,000 | $505K | 50.0% |
| Total | $12.62 avg | 80,000 | $1.0M | 100% |
| Filing → |
| HROW | SELL | 2021-09-27 | $39K | — | Filing → |
| HROW | SELL | 2021-09-17 | $363K | — | Filing → |
| HROW | SELL | 2021-05-21 | $108K | — | Filing → |